B-Raf Inhibition in the Clinic: Present and Future

Annual Review of Medicine
Warren Fiskus, Nicholas Mitsiades

Abstract

Somatic activating mutations in the B-Raf kinase (BRAF mutations) are present in hairy-cell leukemia, cutaneous melanoma, thyroid carcinomas and, less commonly, in ovarian, colon, lung, and other malignancies. These mutations-in particular the most common substitution, V600E-are oncogenic drivers and important therapeutic targets. The development of small-molecule Raf inhibitors allowed rapid translation of basic advances to the clinic. In BRAF-mutant melanomas, orally bioavailable B-Raf inhibitors, such as vemurafenib, achieve dramatic responses initially, but this is followed by rapid emergence of resistance driven by numerous mechanisms and requiring second-generation treatment approaches. In tumors with wild-type B-Raf, vemurafenib paradoxically activates downstream signaling and cell proliferation and is thus contraindicated, highlighting again the importance of genotype-based clinical decision making. These advances were greatly facilitated by the study of biopsied tumor tissue, especially at the time of drug resistance. Combinatorial approaches targeting the Raf pathway hold promise for even more substantial clinical benefits in the future.

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Aug 2, 2002·Cancer Cell·Pamela M Pollock, Paul S Meltzer
Jan 17, 2003·Leukemia·M L SmithJ Fitzgibbon
Aug 15, 2003·The Journal of Biological Chemistry·Armelle CalipelFrédéric Mascarelli
Sep 6, 2003·Cancer Cell·David A TuvesonMeenhard Herlyn
Sep 26, 2003·Oncogene·Toshihiko FukushimaSeiichi Takenoshita
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Oct 19, 2004·Cancer Cell·Mathew J Garnett, Richard Marais
Jan 5, 2005·The Journal of Clinical Investigation·Raffaele CiampiYuri E Nikiforov
Oct 4, 2005·Endocrine Pathology·Raffaele CiampiYuri E Nikiforov
Nov 8, 2005·Nature·David B SolitNeal Rosen
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Jan 21, 2006·Cancer Research·Klaus P HoeflichSomasekar Seshagiri
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Giuliana SalvatoreMassimo Santoro
Mar 23, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bin OuyangJames A Fagin
Jul 1, 2006·Science·Maria Teresa LandiBoris C Bastian
Mar 17, 2007·Molecular Cancer Therapeutics·Constantine S MitsiadesNicholas Mitsiades
Aug 29, 2007·Oncogene·C MichaloglouD S Peeper
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
Dec 2, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·James A Fagin, Nicholas Mitsiades
Sep 4, 2009·Nature·Thanashan RajakulendranMarc Therrien
Jun 4, 2010·Blood·Gayane Badalian-VeryBarrett J Rollins
Jun 8, 2010·Nature Medicine·Nallasivam PalanisamyArul M Chinnaiyan
Jul 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Eric W JosephNeal Rosen
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Nov 26, 2010·Nature·Cory M JohannessenLevi A Garraway
Mar 25, 2011·Nature·Michael A ChapmanTodd R Golub
Jun 4, 2011·Biochemical Pharmacology·Inna V FedorenkoKeiran S M Smalley
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 15, 2011·The New England Journal of Medicine·Enrico TiacciBrunangelo Falini
Aug 11, 2011·Investigative Ophthalmology & Visual Science·Nicholas MitsiadesVassiliki Poulaki
Nov 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John M KirkwoodReinhard Dummer

❮ Previous
Next ❯

Citations

Feb 28, 2016·Acta Neuropathologica·Barbara RiveraJacek Majewski
Jun 28, 2016·Biochimica Et Biophysica Acta·Paulo MatosPeter Jordan
Apr 28, 2017·Archives of Pathology & Laboratory Medicine·Amanda L TreeceAngela N Bartley
Dec 26, 2017·Frontiers in Immunology·Hassan SadozaiMirjam Schenk
Sep 29, 2017·European Respiratory Review : an Official Journal of the European Respiratory Society·Olga TorreSergio Harari
Nov 18, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Liang ChengRodolfo Montironi
Aug 3, 2019·Expert Opinion on Therapeutic Patents·Ruo-Jun ManHai-Liang Zhu
Jan 14, 2020·Cancer Chemotherapy and Pharmacology·Samson GhiluPeter J Houghton
Oct 17, 2017·Cancer Cell International·Tiziana NotarangeloMatteo Landriscina
May 5, 2018·Genes & Cancer·Maria Jesus Herrero, Yorick Gitton
Feb 17, 2017·Biochemical Society Transactions·Coralie DorardManuela Baccarini
Apr 14, 2018·EMBO Molecular Medicine·Ileabett M Echevarría-VargasJessie Villanueva
May 12, 2019·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Shaojun ShiLuc J W van der Laan
Jun 1, 2018·Case Reports in Surgery·Yasar Subutay PekerYusuf Peker
Jan 24, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Santiago Ramón Y CajalJosep Castellví
Apr 30, 2017·Molecular Cancer·Andrea MarranciLaura Poliseno
Jul 22, 2020·Proceedings of the National Academy of Sciences of the United States of America·Angela M CarterJames A Bibb
May 18, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ryan RobbTerence M Williams
Jan 26, 2021·Journal of Pathology and Translational Medicine·Thu Dang Anh PhanTung Thanh Tran
Apr 4, 2021·Clinical Lymphoma, Myeloma & Leukemia·Svetlana Yu SmirnovaAndrey B Sudarikov
May 20, 2021·Protein Science : a Publication of the Protein Society·David E Heppner, Michael J Eck

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
surgical resection

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Expert Opinion on Pharmacotherapy
Juan Martin-Liberal, James Larkin
The New England Journal of Medicine
Animesh Pardanani, Ayalew Tefferi
The New England Journal of Medicine
Yukie TakahashiMasahiro Kami
© 2022 Meta ULC. All rights reserved